In an earlier study, circulating IL-26 levels were found to be significantly elevated in sepsis patients and to be correlated with severity and survival, and peritoneal inflammatory responses were found to be increased in septic mice treated with recombinant human IL-26 [5]. The gene discussed is IL26; the disease is Sepsis.